Inventor · disambiguated record
Yuan Tian
Also filed as: TIAN YUAN
11 granted patents·6 pending applications·47 citations·filing 2006–2025
84Inventor score
Files withMERCK SHARP & DOHME5KEYTHERA SUZHOU BIO PHARMACEUTICALS CO LTD2BEIJING INSTITUTE FOR CANCER RES1BOGEN STEPHANE L1KITE PHARMA INC1
Top patents by PatentIndex Score
17 records- 0190US7884107B2Substituted piperidines that increase P53 activity and the uses thereofMERCK·Filed 2007·Granted Feb 8, 2011·32 cites·36 claims
- 0286US9745265B24-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2013·Granted Aug 29, 2017·9 cites·29 claims
- 0378US10196354B24-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2017·Granted Feb 5, 2019·2 cites·29 claims
- 0469US7652041B2Cinnamide and hydrocinnamide derivatives with kinase inhibitory activityMILLENNIUM PHARM INC·Filed 2006·Granted Jan 26, 2010·1 cites·39 claims
- 0565US8859776B2Substituted piperidines that increase p53 activity and the uses thereofBOGEN STEPHANE L·Filed 2010·Granted Oct 14, 2014·2 cites·44 claims
- 0663US10100064B2Purine inhibitors of human phosphatidylinositol 3-kinase deltaMERCK SHARP & DOHME·Filed 2015·Granted Oct 16, 2018·1 cites·11 claims
- 0761US2024294511A1Solid form of indole compound, preparation method therefor and use thereofKEYTHERA SUZHOU BIO PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0860US2025179499A1Use of cdk16 as target in preparation of medicine for treating triple-negative breast cancerSHENZHEN TYERCAN BIO PHARM CO LTD·Filed 2023·Application pending·0 cites
- 0958US12018335B2Method for quantitatively detecting deletion of human CDKN2A gene copy, primers and use thereofBEIJING INSTITUTE FOR CANCER RES·Filed 2019·Granted Jun 25, 2024·0 cites·5 claims
- 1054US9594086B2Biomarkers for aggressive prostate cancerZHANG HUI·Filed 2012·Granted Mar 14, 2017·0 cites·7 claims
- 1150US2025051324A1Parp inhibitor, pharmaceutical composition comprising same, and use thereofKEYTHERA SUZHOU BIO PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 1250US2014336222A1SUBSTITUTED PIPERIDINES THAT INCREASE p53 ACTIVITY AND THE USES THEREOFMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 1349US11117891B2Isoquinolin and naphthydrin compoundsLILLY CO ELI·Filed 2018·Granted Sep 14, 2021·0 cites·8 claims
- 1444US2025290154A1Predictive markers for immunotherapyKITE PHARMA INC·Filed 2025·Application pending·0 cites
- 1543US2020278353A1Protein Expression Analysis For Breast Cancer Prognosis And TreatmentNANTOMICS LLC·Filed 2018·Application pending·0 cites
- 1642US9062071B2Substituted piperidines as HDM2 inhibitorsMERCK SHARP & DOHME·Filed 2012·Granted Jun 23, 2015·0 cites·16 claims
- 1739US8987274B2Macrocycles that increase p53 activity and the uses thereofNAIR LATHA G·Filed 2012·Granted Mar 24, 2015·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Yuan Tian files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →